| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |